Cognitive behavioural therapy (CBT) for dysphonia: a trial platform

ISRCTN ISRCTN20582523
DOI https://doi.org/10.1186/ISRCTN20582523
Secondary identifying numbers 4588; G0501875
Submission date
19/05/2010
Registration date
19/05/2010
Last edited
12/02/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Mr Vincent Deary
Scientific

Institute of Health and Society
21-23 Claremont Place
Newcastle Upon Tyne
NE2 4AA
United Kingdom

ORCiD logoORCID ID 0000-0001-6115-9259

Study information

Study designSingle-centre randomised interventional treatment trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleTraining a speech and language therapist in cognitive behavioural therapy to treat functional dysphonia: a randomised controlled trial
Study acronymCBT for dysphonia
Study hypothesisThe principle purpose of this trial is to see if giving a speech and language therapist a brief training in cognitive behavioural therapy (CBT), and then having that therapist deliver CBT "enhanced" voice therapy, can improve the quality of life of people suffering from medically unexplained hoarseness and voice loss. This voice problem, known as "functional dysphonia", is associated with increased anxiety and depression, and with poor general health. Voice therapy alone improves voice, but seems to have no impact on this associated distress. Our hypothesis therefore is that the addition of CBT skills to conventional voice therapy will improve anxiety and depression in this patient group more than voice therapy alone.
Ethics approval(s)Newcastle amd North Tyneside REC, 27/07/2007, ref: 07/H0906/118
ConditionTopic: Ear; Subtopic: Ear (all Subtopics); Disease: Ear, nose & throat
InterventionVoice Therapy:
This "treatment as usual" will aim to be as close to standard voice therapy practice as possible. Patients will be offered 6 - 8 sessions, weekly to fortnightly, of approximately one hour's voice therapy. This represents an average length of a voice therapy course in the UK. The content will typically have the following elements:
1. Voice care and education on use
2. Elimination of voice misuse and abuse
3. Breath control, breathing and speaking coordination

Voice Therapy plus CBT:
The approximate number and timing of sessions will be the same as in the voice therapy alone arm. The treatment will be couched within an overarching CBT framework, the key component of this being that an explanatory model of the patient's condition will be collaboratively established, and the key factors maintaining both vocal problems and distress will be identified. This model will then be used to structure the treatment.

Length of treatment will be six to eight sessions, fortnightly and patients will be followed up to six months post-discharge from treatment.
Intervention typeOther
Primary outcome measurePsychological distress, measured using the Hospital Anxiety and Depression Scale (HADS). Outcomes will be taken at baseline, discharge and six months post-discharge
Secondary outcome measures1. Psychological distress, measured using the General Health Questionnaire
2. The Chalder Fatigue Scale
3. The Work and Social Adjustment Scale
4. Voice, measured using the Voice Performance Questionnaire (VPQ)

Outcomes will be taken at baseline, discharge and six months post-discharge.
Overall study start date29/10/2007
Overall study end date30/09/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsPlanned sample size: 62
Participant inclusion criteria1. Patients of either sex who are over 16 years
2. Diagnosed by an expert speech and language therapist as having functional dysphonia
3. Clinical assessment involving larygoscope to exclude other causes
Participant exclusion criteria1. Previous experience of cognitive behavioural therapy (CBT) for voice problem
2. Acute or ongoing serious medical illness
3. Suffer from a severe mental health problem (for example major depression, psychotic illnesses, or alcohol dependence)
4. Learning disability
5. Vocal condition that does not merit a full course of treatment
6. Score of less than 1 on a standardised measure of voice quality (the Grade, Roughness, Breathiness, Aesthenia, Strain [GRBAS] Scale)
7. Do not speak English
Recruitment start date29/10/2007
Recruitment end date30/09/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Institute of Health and Society
Newcastle Upon Tyne
NE2 4AA
United Kingdom

Sponsor information

Newcastle upon Tyne Hospitals NHS Trust (UK)
Hospital/treatment centre

Queen Victoria Road
Newcastle Upon Tyne
NE1 4LP
England
United Kingdom

Website http://www.newcastle-hospitals.org.uk/
ROR logo "ROR" https://ror.org/05p40t847

Funders

Funder type

Research council

Medical Research Council (MRC) (UK) (ref: G0501875)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2018 Yes No

Editorial Notes

12/02/2018: Publication reference added.